AST SpaceMobile just defied gravity, surging over 14% to a fresh all-time high after securing a prime spot on the U.S. Missile Defense Agency’s massive SHIELD program. With a contract ceiling of $151 billion, Wall Street is betting that ASTS is no longer just a cellular play—it’s a critical defense asset. In this episode of Implied, we break down how this "dual-use" validation changes the narrative, why investors are ignoring the dizzying 3,000x sales valuation, and whether AST can actually compete against titans like Lockheed Martin. Is this the start of a new era, or is the stock priced for perfection? Tune in to find out.